Clinical Trial Update: A Study of the Epidemiology and Hospital Management of Patients With PROS in France

View source ↗

Summary

This completed French study investigates the epidemiology and hospital management of patients with PIK3CA-related overgrowth spectrum (PROS). It is sponsored by…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pik3ca-related Overgrowth Spectrum

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: PIK3CA-Related Overgrowth Spectrum | Status: COMPLETED